The Department of Justice has agreed to further postpone a case challenging the administrative process behind the marijuana rescheduling proposal being considered by the Trump administration.
In a joint filing with the U.S. District Court for the Western District of Washington, DOJ and plaintiff Panacea Plant Sciences (PPS) founder and CEO David Heldreth said that, because there haven’t been any recent advancements in the broader rescheduling issue, the separate litigation related to administrative procedures should continue to be stayed through the end of the year.
That is not necessarily a reflection of the status of the Trump administration’s rescheduling process. Rather, it is directly responsive to litigation over how the federal government approaches scheduling actions. The president said late last month that he would be making a decision on the overarching proposal to move marijuana to Schedule III of the Controlled Substances Act (CSA) within weeks.
But for now, because the administrative hearing process remains stalled, both DOJ and PPS told the court that the stay should be kept in place until January 27, 2026, when another joint report from the parties will be due.
Last January, the court approved a prior stay request for the same reasons. Then in
Read full article on Marijuana Moment
